The major factors driving the growth of Pharmaceutical Membrane Filtration Market are the increasing adoption of single-use technologies and the growing demand for nanofiltration. Geographical expansion in countries such as Singapore, France, China, and India and the demand for polyamide track-etched membranes in ultrafiltration are likely to provide growth opportunities for players in the market.

The global pharmaceutical membrane filtration market is projected to reach USD 10.2 billion by 2025 from USD 5.8 billion in 2020, growing at a CAGR of 12.0% during the forecast period.

Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=255408031

KEY MARKET DYNAMICS
1 DRIVERS
1 Increasing usage of single-use technologies
2 Nanofiltration technology
2 OPPORTUNITIES
1 Geographical expansion
2 Ultrafiltration track-etched membranes
3 BURNING ISSUES
1 Intense competition in the market—a critical barrier for new entrants
4 IMPACT OF COVID-19 OUTBREAK ON THE PHARMACEUTICAL MEMBRANE FILTRATION MARKET
1 Impact on the pharmaceutical membrane filtration market

Market Segmentation :

On the basis of product, the market is segmented into filters, systems, and accessories. Filters formed the largest product segment in this market owing to the high and growing use of different types of membrane filters for various filtration applications in the biopharmaceutical manufacturing industry.
On the basis of technique, the pharmaceutical membrane filtration market is segmented into microfiltration, ultrafiltration, nanofiltration, reverse osmosis, and ion exchange. Microfiltration segment accounted for the largest share of the market in 2019. Microfiltration is one of the oldest and most commonly used techniques for the separation of large-molecular-weight suspended or colloidal compounds from dissolved solids.
On the basis of application, the market is segmented into final product processing, raw material filtration, cell separation, water purification, and air purification. Final product processing was the largest application segment in the market in 2019. The increasing production of generics, rapid growth in the biopharmaceutical industry, and the increasing adoption of membrane filters in protein purification, sterile filtration, and viral clearance processes are the major factors driving the growth of this application segment.

Regional Analysis:
The global pharmaceutical membrane filtration market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2019, North America was the largest market for pharmaceutical membrane filtration, followed by Europe. The large share of North America can be attributed to several factors, such as the presence of key biopharmaceutical manufacturing facilities in the region and the significant spending on research and development activities in the US.

Request for Customization: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=255408031

Recent Developments:
• In 2020, Merck invested USD 280.3 million in a new facility—the Merck Biotech Development Center in Corsier-sur-Vevey, Switzerland.
• In 2019, Koch Membrane Systems launched Sani-Pro Spiral Element Product Line.
• In 2018, Pall Corporation partnered with BioSciencesCorp to provide drug manufacturers with direct access to Pall Biotech’s downstream technologies, including pharmaceutical membrane filtration.

Top Key Players:

The major companies operating in the pharmaceutical membrane filtration market include Merck (Germany), Danaher (US) and Sartorius Stedim Biotech (France).